当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Stuart Farquharson, Zack Gladding, Carl Brouillette, Wayne Smith, Amelia Farquharson, Chetan Shende
Medication is the primary defense against the deleterious effects that astronauts experience in space due to weightlessness, such bone loss and headaches. Recent studies of medications returned to earth from the International Space Station suggest that high radiation levels of solar particle events (SPE) and galactic cosmic rays (GCR) can degrade medications, and potentially render them inadequate during a long mission, such as a roundtrip journey to Mars. In an effort to predict medication shelf-lives, proton irradiation at ground-based laboratories has been used to simulate SPE and GRC conditions, as quantified by high-performance liquid chromatography. Unfortunately,such predictions do not take into account extreme SPEs and/or CGRs that can occur during such long duration missions.We believe that medications, the active pharmaceutical ingredient, as well as the potentially toxic degradants, can be tested on-board space crafts at the time of use by a compact Raman spectrometer. Here we present the forced degradation of an aspirin tablet by acid hydrolysis, representing the high energy protons that make up ~85% of the SPEs and CGRs.Raman analyses of this tablet, and 10 expired twelve-year-old aspirin tablets and their toxic degradant, salicylic acid,are presented.